Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 387

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy

Open access
Goh, Gerald, Walradt, Trent, Markarov, Vladimir, Blom, Astrid, Riaz, Nadeem, Doumani, Ryan, Stafstrom, Krista, Moshiri, Ata, Yelistratova, Lola, Levinsohn, Jonathan, Chan, Timothy A., Nghiem, Paul, Lifton, Richard P., Choi, Jaehyuk·2016·Oncotarget

Abstract

// Gerald Goh 1, 2 , Trent Walradt 3 , Vladimir Markarov 4 , Astrid Blom 5 , Nadeem Riaz 6, 7 , Ryan Doumani 5 , Krista Stafstrom 5 , Ata Moshiri 5 , Lola Yelistratova 5 , Jonathan Levinsohn 3 , Timothy A. Chan 4, 6 , Paul Nghiem 5, 7, 8 , Richard P. Lifton 1, 2 , Jaehyuk Choi 3, 9, 10 1 Department of Genetics, Yale School of Medicine, New Haven, CT, USA 2 Howard Hughes Medical Institute, Yale School of Medicine, New Haven, CT, USA 3 Department of Dermatology, Yale School of Medicine, New Haven, CT, USA 4 Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 5 Department of Dermatology, University of Washington, Seattle, WA, USA 6 Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA 7 Department of Pathology, University of Washington, Seattle, WA, USA 8 Fred Hutchinson Cancer Center, Seattle, WA, USA 9 Department of Dermatology, Veterans Affairs Healthcare, West Haven, CT, USA 10 Current address: Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA Correspondence to: Jaehyuk Choi, e-mail: Jaehyuk.choi@northwestern.edu Richard P. Lifton, e-mail: richard.lifton@yale.edu Keywords: Merkel cell carcinoma, merkel cell polyomavirus, TP53, cancer genetics, tumor neoantigens Received: August 27, 2015 Accepted: November 20, 2015 Published: December 07, 2015 ABSTRACT Merkel cell carcinoma (MCC) is a rare but highly aggressive cutaneous neuroendocrine carcinoma, associated with the Merkel cell polyomavirus (MCPyV) in 80% of cases. To define the genetic basis of MCCs, we performed exome sequencing of 49 MCCs. We show that MCPyV-negative MCCs have a high mutation burden (median of 1121 somatic single nucleotide variants (SSNVs) per-exome with frequent mutations in RB1 and TP53 and additional damaging mutations in genes in the chromatin modification ( ASXL1, MLL2 , and MLL3 ), JNK ( MAP3K1 and TRAF7 ), and DNA-damage pathways ( ATM, MSH2 , and BRCA1 ). In contrast, MCPyV-positive MCCs harbor few SSNVs (median of 12.5 SSNVs/tumor) with none in the genes listed above. In both subgroups, there are rare cancer-promoting mutations predicted to activate the PI3K pathway ( HRAS, KRAS, PIK3CA, PTEN , and TSC1 ) and to inactivate the Notch pathway ( Notch1 and Notch2 ). TP53 mutations appear to be clinically relevant in virus-negative MCCs as 37% of these tumors harbor potentially targetable gain-of-function mutations in TP53 at p.R248 and p.P278. Moreover, TP53 mutational status predicts death in early stage MCC (5-year survival in TP53 mutant vs wild-type stage I and II MCCs is 20% vs. 92%, respectively; P = 0.0036). Lastly, we identified the tumor neoantigens in MCPyV-negative and MCPyV-positive MCCs. We found that virus-negative MCCs harbor more tumor neoantigens than melanomas or non-small cell lung cancers (median of 173, 65, and 111 neoantigens/sample, respectively), two cancers for which immune checkpoint blockade can produce durable clinical responses. Collectively, these data support the use of immunotherapies for virus-negative MCCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.6494

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 387

Metadata

Authors
Goh, G., Walradt, T., Markarov, V., Blom, A., Riaz, N., Doumani, R., Stafstrom, K., Moshiri, A., Yelistratova, L., Levinsohn, J., Chan, T. A., Nghiem, P., Lifton, R. P., & Choi, J.
Venue
Oncotarget
Published
2015-12-07
Volume
7
Issue
3
Pages
3403-3415
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2283046649
Cited by
387
References
10
FWCI
13.13
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. https://app.cochat.ai/papers/10.18632/oncotarget.6494
The paper
Goh, G., Walradt, T., Markarov, V., Blom, A., Riaz, N., Doumani, R., Stafstrom, K., Moshiri, A., Yelistratova, L., Levinsohn, J., Chan, T. A., Nghiem, P., Lifton, R. P., & Choi, J. (2016). Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget. https://doi.org/10.18632/oncotarget.6494

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.